Kenya vs Lithuania: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Kenya
87.0%
in 2025
Lithuania
87.0%
in 2025
Kenya rank
86th
Lithuania rank
86th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Kenya
- Lithuania
How they compare
Kenya currently reports 87.0% against 87.0% in Lithuania, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Lithuania ahead.
Kenya ranks 86th and Lithuania ranks 86th of 194 countries.
Kenya has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kenya | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 75.1% | 32.9% | 42.2% | Kenya |
| 2020s | 91.0% | 83.7% | 7.3% | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Kenya or Lithuania?
- Kenya, at 87.0% against 87.0% in Lithuania as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Kenya and Lithuania?
- 0.0%, with Kenya ahead.
- How many years of comparable data are there for Kenya and Lithuania?
- 18 years are reported by both, from 2008 to 2025.
- How do Kenya and Lithuania rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Kenya ranks 86th and Lithuania ranks 86th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.